169 filings
8-K
CNTX
Context Therapeutics Inc
1 Apr 24
Important Regulatory Milestone Supports Next Phase of CTIM-76 Development
7:32am
4
Jennifer Lynn Minai-Azary
22 Mar 24
Context Therapeutics / Jennifer Lynn Minai-Azary ownership change
8:04am
4
Alex C. Levit
22 Mar 24
Context Therapeutics / Alex C. Levit ownership change
8:01am
4
Martin A. Lehr
22 Mar 24
Context Therapeutics / Martin A. Lehr ownership change
8:01am
S-8
CNTX
Context Therapeutics Inc
21 Mar 24
Registration of securities for employees
8:28am
10-K
2023 FY
CNTX
Context Therapeutics Inc
Annual report
21 Mar 24
7:36am
8-K
CNTX
Context Therapeutics Inc
21 Mar 24
Amendments to Articles of Incorporation or Bylaws
7:31am
8-K
CNTX
Context Therapeutics Inc
6 Mar 24
March 2024 Corporate Presentation Advancing Medicines for Solid Tumors
7:30am
SC 13G/A
Affinity Asset Advisors, LLC
13 Feb 24
Context Therapeutics / Affinity Asset Advisors ownership change
4:45pm
SC 13G/A
CNTX
Context Therapeutics Inc
7 Feb 24
Context Therapeutics / Lehr Martin A. ownership change
4:24pm
SC 13G
CNTX
Context Therapeutics Inc
5 Jan 24
Context Therapeutics / Opaleye Management ownership change
4:05pm
10-Q
2023 Q3
CNTX
Context Therapeutics Inc
Quarterly report
9 Nov 23
4:04pm
8-K
CNTX
Context Therapeutics Inc
31 Oct 23
Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76
9:04am
10-Q
2023 Q2
CNTX
Context Therapeutics Inc
Quarterly report
9 Aug 23
4:04pm
8-K
CNTX
Context Therapeutics Inc
7 Aug 23
August 2023 Corporate Presentation Advancing Medicines for Solid Tumors
8:11am
8-K
CNTX
Context Therapeutics Inc
20 Jun 23
Other Events
8:35am
8-K
CNTX
Context Therapeutics Inc
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
4
CNTX
Context Therapeutics Inc
31 May 23
Context Therapeutics / Philip W. Kantoff ownership change
4:53pm
4
CNTX
Context Therapeutics Inc
31 May 23
Context Therapeutics / Linda West ownership change
4:53pm
4
CNTX
Context Therapeutics Inc
31 May 23
Context Therapeutics / Jennifer Evans Stacey ownership change
4:53pm